Pipeline
CTIM-76 is a bispecific antibody designed to target CLDN6+ cancer cells while minimizing T-cell activation.
contexttherapeutics.comCrawled Nov 22, 2026
CTIM-76 is a bispecific antibody designed to target CLDN6+ cancer cells while minimizing T-cell activation.
Clinical trial evaluating Onapristone plus Elacestrant in HR+,HER2- breast cancer
Context Therapeutics Policy for Evaluating Expanded Access to Investigational Agents Outside of Context Therapeutics Clinical Trials
Trial Status: Enrollment in this Phase 2 study is completed.
Granulosa cell ovarian tumor clinical trial in Greater Metropolitan New York City Region
There are approximately 750,000 metastatic breast cancer patients worldwide. Of those patients, 50-70% have breast cancer that is driven by aberrant hormone signaling via activation of progesterone receptor (PR) and/or estrogen receptor (ER) signaling.
2018 San Antonio Breast Cancer Symposium
By understanding the challenges associated with Investigator Sponsored Trials (IST), stakeholders can utilize ISTs to deliver high-contrast clinical data on underserved patients.
Stanley Roberts, Kelly Byrnes-Blake, Bruce Hug, and Eric Butz
Rodriguez Rivera et al. Society for Immunotherapy of Cancer (SITC) I Annual Meeting I Abstract 536 I November 7-9, 2025
Roisin E. O’Cearbhaill et al. American Society of Clinical Oncology I Annual Meeting I Abstract TPS2685 I May 30-June 3, 2025
Stanley A. Roberts, Kelly Byrnes-Blake, Heather Ansorge, Eric Butz Society for Immunotherapy of Cancer (SITC) I Annual Meeting I Abstract 963 I November 7-9, 2025
Summary collection of all news articles about Context Therapeutics.
Stanley Roberts, Kelly Byrnes-Blake, Bruce Hug, and Eric Butz American Association for Cancer Research (AACR) I Annual Meeting I Abstract 5392 I April 2026
The VP / Senior Director of Regulatory Affairs builds regulatory strategies for Context Therapeutics’ investigational products.
The page lists careers available at Context Therapeutics.
The Clinical Trial Associate, Clinical Operations oversees clinical studies for Context Therapeutics.
The Senior Manager / Associate Director, Clinical Operations oversees clinical studies for Context Therapeutics.
The Clinical Data Manager supports clinical studies for Context Therapeutics.
The Head of Global Regulatory Affairs leads regulatory strategy for Context Therapeutics.
The Senior Accountant supports financial reporting and compliance at Context Therapeutics.
The page introduces the Context Therapeutics team.
The page introduces Context Therapeutics’ scientific advisors.
The Executive Director of External Manufacturing & Supply Chain leads Context Therapeutics’ global external manufacturing and clinical supply network.
The page introduces Context Therapeutics’ directors.
The Executive Director of Quality designs and implements a risk-based Quality Management System for Context Therapeutics.
The page introduces Context Therapeutics’ management team.
Context Therapeutics is based in Philadelphia, PA. You can reach us by email at info@contexttherapeutics.com.
The Context Therapeutic team believes that innovation is driven by the cross-fertilization of ideas between interdisciplinary teams.
Summary of Context Therapeutics clinical trials.